Pfizer and BioNTech said Friday that the immune responses against Omicron BA.4/BA.5 subvariants were "substantially higher" in people who got its new bivalent booster compared with people who received ...

RALEIGH, N.C. (WTVD) -- Local, county and state leaders across the country are awaiting guidance from the Food and Drug Administration and the Centers for Disease Control on the fate of the ...

On Tuesday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Pfizer vaccine should now seek out a booster shot five months after ...

March 1 (Reuters) - Pfizer Inc (PFE.N), opens new tab and its German partner BioNTech SE (22UAy.DE), opens new tab have applied for emergency use authorization of their Omicron-adapted COVID-19 ...

In a recent study published in The Lancet Respiratory Medicine, a team of researchers from the United States (U.S.) examined the efficacy of the bivalent Pfizer-BioNTech coronavirus disease 2019 ...

In the first real-world test of vaccine boosters specially designed to protect against the Omicron variant, Israeli researchers have found that people 65 and older who got an updated jab were 81% less ...

The Food and Drug Administration has issued approval for a booster shot of Pfizer's COVID-19 vaccine for children as young as 12. The Pfizer vaccine is the first booster shot to receive emergency ...

Pfizer Inc.’s bivalent shot for COVID-19 has received emergency approval to be used as a booster in some infants and toddlers. Children between six months and four years old can receive the ...

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least two ...

Upon authorization by the European Commission (EC), the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...

ERIKA: NEW NATIONAL DATA SHOWS AN OVERWHELMING MAJORITY OF AMERICANS, IN EVERY AGE GROUP, STILL HAVEN'T RECEIVED AN UPDATED BOOSTER SHOT FOR COVID-19. HERE TO ANSWER QUESTIONS IS DR. DANIEL KURITZKES, ...